<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Wed, 25 Feb 2026 16:15:00 -0500</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  6-K        Nanobiotix S.A.           For: Feb 25</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nanobiotix+S.A.+++++++++++For%3A+Feb+25/26060192.html</link>
   <description>si-local-file:///var/storage/secattach/20260225/26060192.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nanobiotix+S.A.+++++++++++For%3A+Feb+25/26060192.html</guid>
   <pubDate>Wed, 25 Feb 2026 16:15:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NANO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01217207</category>
   	  </item>
  <item>
   <title>Form  6-K        Nanobiotix S.A.           For: Feb 25</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nanobiotix+S.A.+++++++++++For%3A+Feb+25/26060192.html</link>
   <description>si-local-file:///var/storage/secattach/20260225/26060192.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nanobiotix+S.A.+++++++++++For%3A+Feb+25/26060192.html</guid>
   <pubDate>Wed, 25 Feb 2026 16:15:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NANO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01217207</category>
   	  </item>
  <item>
   <title>Form  6-K        Nanobiotix S.A.           For: Feb 25</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nanobiotix+S.A.+++++++++++For%3A+Feb+25/26060192.html</link>
   <description>si-local-file:///var/storage/secattach/20260225/26060192.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nanobiotix+S.A.+++++++++++For%3A+Feb+25/26060192.html</guid>
   <pubDate>Wed, 25 Feb 2026 16:15:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NANO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01217207</category>
   	  </item>
  <item>
   <title>NANOBIOTIX to Participate in Investor Conferences in March</title>
   <link>http://www.streetinsider.com/Press+Releases/NANOBIOTIX+to+Participate+in+Investor+Conferences+in+March/26060141.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;PARIS and CAMBRIDGE, Mass., Feb.  25, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=vHgpCO40iAZGYCp6BLxel1WeDFDvutfjx_EDYBx1ofPoE3VgXVBbi7fcfLrev044vByl4GgwdZ8WHEfmHGpEYw==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;NANOBIOTIX&lt;/a&gt; (Euronext: NANO - NASDAQ: NBTX - the “&lt;strong&gt;Company&lt;/strong&gt;”), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases, announced today that Company management will participate in these upcoming conferences in March:&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;TD Cowen&amp;apos;s Health Care Conference&lt;/strong&gt;&lt;br/&gt;Date: Wednesday, March 4, 2026&lt;br/&gt;Location: Boston, MA&lt;br/&gt;Time of the fireside chat: 11:10am ET / 5:10pm CET&lt;br/&gt;Presenters: Laurent Levy, Chief Executive Officer of Nanobiotix and Bart van Rhijn, Chief Financial &amp;amp; Business Officer of Nanobiotix&lt;/p&gt; </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/NANOBIOTIX+to+Participate+in+Investor+Conferences+in+March/26060141.html</guid>
   <pubDate>Wed, 25 Feb 2026 16:15:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50100012</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NANO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01217207</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.07579093</category>
   	  </item>
  <item>
   <title>NANOBIOTIX to Participate in Investor Conferences in March</title>
   <link>http://www.streetinsider.com/Press+Releases/NANOBIOTIX+to+Participate+in+Investor+Conferences+in+March/26060141.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;PARIS and CAMBRIDGE, Mass., Feb.  25, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=vHgpCO40iAZGYCp6BLxel1WeDFDvutfjx_EDYBx1ofPoE3VgXVBbi7fcfLrev044vByl4GgwdZ8WHEfmHGpEYw==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;NANOBIOTIX&lt;/a&gt; (Euronext: NANO - NASDAQ: NBTX - the “&lt;strong&gt;Company&lt;/strong&gt;”), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases, announced today that Company management will participate in these upcoming conferences in March:&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;TD Cowen&amp;apos;s Health Care Conference&lt;/strong&gt;&lt;br/&gt;Date: Wednesday, March 4, 2026&lt;br/&gt;Location: Boston, MA&lt;br/&gt;Time of the fireside chat: 11:10am ET / 5:10pm CET&lt;br/&gt;Presenters: Laurent Levy, Chief Executive Officer of Nanobiotix and Bart van Rhijn, Chief Financial &amp;amp; Business Officer of Nanobiotix&lt;/p&gt; </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/NANOBIOTIX+to+Participate+in+Investor+Conferences+in+March/26060141.html</guid>
   <pubDate>Wed, 25 Feb 2026 16:15:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50100012</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NANO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01217207</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.07579093</category>
   	  </item>
  <item>
   <title>NANOBIOTIX to Participate in Investor Conferences in March</title>
   <link>http://www.streetinsider.com/Press+Releases/NANOBIOTIX+to+Participate+in+Investor+Conferences+in+March/26060141.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;PARIS and CAMBRIDGE, Mass., Feb.  25, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=vHgpCO40iAZGYCp6BLxel1WeDFDvutfjx_EDYBx1ofPoE3VgXVBbi7fcfLrev044vByl4GgwdZ8WHEfmHGpEYw==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;NANOBIOTIX&lt;/a&gt; (Euronext: NANO - NASDAQ: NBTX - the “&lt;strong&gt;Company&lt;/strong&gt;”), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases, announced today that Company management will participate in these upcoming conferences in March:&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;TD Cowen&amp;apos;s Health Care Conference&lt;/strong&gt;&lt;br/&gt;Date: Wednesday, March 4, 2026&lt;br/&gt;Location: Boston, MA&lt;br/&gt;Time of the fireside chat: 11:10am ET / 5:10pm CET&lt;br/&gt;Presenters: Laurent Levy, Chief Executive Officer of Nanobiotix and Bart van Rhijn, Chief Financial &amp;amp; Business Officer of Nanobiotix&lt;/p&gt; </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/NANOBIOTIX+to+Participate+in+Investor+Conferences+in+March/26060141.html</guid>
   <pubDate>Wed, 25 Feb 2026 16:15:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50100012</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NANO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01217207</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.07579093</category>
   	  </item>
  <item>
   <title>NANOBIOTIX to Participate in Investor Conferences in March</title>
   <link>http://www.streetinsider.com/Press+Releases/NANOBIOTIX+to+Participate+in+Investor+Conferences+in+March/26060141.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;PARIS and CAMBRIDGE, Mass., Feb.  25, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=vHgpCO40iAZGYCp6BLxel1WeDFDvutfjx_EDYBx1ofPoE3VgXVBbi7fcfLrev044vByl4GgwdZ8WHEfmHGpEYw==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;NANOBIOTIX&lt;/a&gt; (Euronext: NANO - NASDAQ: NBTX - the “&lt;strong&gt;Company&lt;/strong&gt;”), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases, announced today that Company management will participate in these upcoming conferences in March:&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;TD Cowen&amp;apos;s Health Care Conference&lt;/strong&gt;&lt;br/&gt;Date: Wednesday, March 4, 2026&lt;br/&gt;Location: Boston, MA&lt;br/&gt;Time of the fireside chat: 11:10am ET / 5:10pm CET&lt;br/&gt;Presenters: Laurent Levy, Chief Executive Officer of Nanobiotix and Bart van Rhijn, Chief Financial &amp;amp; Business Officer of Nanobiotix&lt;/p&gt; </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/NANOBIOTIX+to+Participate+in+Investor+Conferences+in+March/26060141.html</guid>
   <pubDate>Wed, 25 Feb 2026 16:15:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50100012</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NANO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01217207</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.07579093</category>
   	  </item>
  <item>
   <title>NANOBIOTIX to Participate in Investor Conferences in March</title>
   <link>http://www.streetinsider.com/Press+Releases/NANOBIOTIX+to+Participate+in+Investor+Conferences+in+March/26060141.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;PARIS and CAMBRIDGE, Mass., Feb.  25, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=vHgpCO40iAZGYCp6BLxel1WeDFDvutfjx_EDYBx1ofPoE3VgXVBbi7fcfLrev044vByl4GgwdZ8WHEfmHGpEYw==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;NANOBIOTIX&lt;/a&gt; (Euronext: NANO - NASDAQ: NBTX - the “&lt;strong&gt;Company&lt;/strong&gt;”), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases, announced today that Company management will participate in these upcoming conferences in March:&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;TD Cowen&amp;apos;s Health Care Conference&lt;/strong&gt;&lt;br/&gt;Date: Wednesday, March 4, 2026&lt;br/&gt;Location: Boston, MA&lt;br/&gt;Time of the fireside chat: 11:10am ET / 5:10pm CET&lt;br/&gt;Presenters: Laurent Levy, Chief Executive Officer of Nanobiotix and Bart van Rhijn, Chief Financial &amp;amp; Business Officer of Nanobiotix&lt;/p&gt; </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/NANOBIOTIX+to+Participate+in+Investor+Conferences+in+March/26060141.html</guid>
   <pubDate>Wed, 25 Feb 2026 16:15:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50100012</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NANO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01217207</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.07579093</category>
   	  </item>
  <item>
   <title>NANOBIOTIX to Participate in Investor Conferences in March</title>
   <link>http://www.streetinsider.com/Globe+Newswire/NANOBIOTIX+to+Participate+in+Investor+Conferences+in+March/26060141.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;PARIS and CAMBRIDGE, Mass., Feb.  25, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=vHgpCO40iAZGYCp6BLxel1WeDFDvutfjx_EDYBx1ofPoE3VgXVBbi7fcfLrev044vByl4GgwdZ8WHEfmHGpEYw==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;NANOBIOTIX&lt;/a&gt; (Euronext: NANO - NASDAQ: NBTX - the “&lt;strong&gt;Company&lt;/strong&gt;”), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases, announced today that Company management will participate in these upcoming conferences in March:&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;TD Cowen&amp;apos;s Health Care Conference&lt;/strong&gt;&lt;br/&gt;Date: Wednesday, March 4, 2026&lt;br/&gt;Location: Boston, MA&lt;br/&gt;Time of the fireside chat: 11:10am ET / 5:10pm CET&lt;br/&gt;Presenters: Laurent Levy, Chief Executive Officer of Nanobiotix and Bart van Rhijn, Chief Financial &amp;amp; Business Officer of Nanobiotix&lt;/p&gt; </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/NANOBIOTIX+to+Participate+in+Investor+Conferences+in+March/26060141.html</guid>
   <pubDate>Wed, 25 Feb 2026 16:15:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50100012</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NANO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01217207</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.07579093</category>
   	  </item>
  <item>
   <title>NANOBIOTIX to Participate in Investor Conferences in March</title>
   <link>http://www.streetinsider.com/Globe+Newswire/NANOBIOTIX+to+Participate+in+Investor+Conferences+in+March/26060141.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;PARIS and CAMBRIDGE, Mass., Feb.  25, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=vHgpCO40iAZGYCp6BLxel1WeDFDvutfjx_EDYBx1ofPoE3VgXVBbi7fcfLrev044vByl4GgwdZ8WHEfmHGpEYw==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;NANOBIOTIX&lt;/a&gt; (Euronext: NANO - NASDAQ: NBTX - the “&lt;strong&gt;Company&lt;/strong&gt;”), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases, announced today that Company management will participate in these upcoming conferences in March:&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;TD Cowen&amp;apos;s Health Care Conference&lt;/strong&gt;&lt;br/&gt;Date: Wednesday, March 4, 2026&lt;br/&gt;Location: Boston, MA&lt;br/&gt;Time of the fireside chat: 11:10am ET / 5:10pm CET&lt;br/&gt;Presenters: Laurent Levy, Chief Executive Officer of Nanobiotix and Bart van Rhijn, Chief Financial &amp;amp; Business Officer of Nanobiotix&lt;/p&gt; </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/NANOBIOTIX+to+Participate+in+Investor+Conferences+in+March/26060141.html</guid>
   <pubDate>Wed, 25 Feb 2026 16:15:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50100012</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NANO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01217207</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.07579093</category>
   	  </item>
  <item>
   <title>NANOBIOTIX to Participate in Investor Conferences in March</title>
   <link>http://www.streetinsider.com/Globe+Newswire/NANOBIOTIX+to+Participate+in+Investor+Conferences+in+March/26060141.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;PARIS and CAMBRIDGE, Mass., Feb.  25, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=vHgpCO40iAZGYCp6BLxel1WeDFDvutfjx_EDYBx1ofPoE3VgXVBbi7fcfLrev044vByl4GgwdZ8WHEfmHGpEYw==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;NANOBIOTIX&lt;/a&gt; (Euronext: NANO - NASDAQ: NBTX - the “&lt;strong&gt;Company&lt;/strong&gt;”), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases, announced today that Company management will participate in these upcoming conferences in March:&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;TD Cowen&amp;apos;s Health Care Conference&lt;/strong&gt;&lt;br/&gt;Date: Wednesday, March 4, 2026&lt;br/&gt;Location: Boston, MA&lt;br/&gt;Time of the fireside chat: 11:10am ET / 5:10pm CET&lt;br/&gt;Presenters: Laurent Levy, Chief Executive Officer of Nanobiotix and Bart van Rhijn, Chief Financial &amp;amp; Business Officer of Nanobiotix&lt;/p&gt; </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/NANOBIOTIX+to+Participate+in+Investor+Conferences+in+March/26060141.html</guid>
   <pubDate>Wed, 25 Feb 2026 16:15:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50100012</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NANO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01217207</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.07579093</category>
   	  </item>
  <item>
   <title>NANOBIOTIX to Participate in Investor Conferences in March</title>
   <link>http://www.streetinsider.com/Globe+Newswire/NANOBIOTIX+to+Participate+in+Investor+Conferences+in+March/26060141.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;PARIS and CAMBRIDGE, Mass., Feb.  25, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=vHgpCO40iAZGYCp6BLxel1WeDFDvutfjx_EDYBx1ofPoE3VgXVBbi7fcfLrev044vByl4GgwdZ8WHEfmHGpEYw==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;NANOBIOTIX&lt;/a&gt; (Euronext: NANO - NASDAQ: NBTX - the “&lt;strong&gt;Company&lt;/strong&gt;”), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases, announced today that Company management will participate in these upcoming conferences in March:&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;TD Cowen&amp;apos;s Health Care Conference&lt;/strong&gt;&lt;br/&gt;Date: Wednesday, March 4, 2026&lt;br/&gt;Location: Boston, MA&lt;br/&gt;Time of the fireside chat: 11:10am ET / 5:10pm CET&lt;br/&gt;Presenters: Laurent Levy, Chief Executive Officer of Nanobiotix and Bart van Rhijn, Chief Financial &amp;amp; Business Officer of Nanobiotix&lt;/p&gt; </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/NANOBIOTIX+to+Participate+in+Investor+Conferences+in+March/26060141.html</guid>
   <pubDate>Wed, 25 Feb 2026 16:15:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50100012</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NANO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01217207</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.07579093</category>
   	  </item>
  <item>
   <title>NANOBIOTIX to Participate in Investor Conferences in March</title>
   <link>http://www.streetinsider.com/Globe+Newswire/NANOBIOTIX+to+Participate+in+Investor+Conferences+in+March/26060141.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;PARIS and CAMBRIDGE, Mass., Feb.  25, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=vHgpCO40iAZGYCp6BLxel1WeDFDvutfjx_EDYBx1ofPoE3VgXVBbi7fcfLrev044vByl4GgwdZ8WHEfmHGpEYw==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;NANOBIOTIX&lt;/a&gt; (Euronext: NANO - NASDAQ: NBTX - the “&lt;strong&gt;Company&lt;/strong&gt;”), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases, announced today that Company management will participate in these upcoming conferences in March:&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;TD Cowen&amp;apos;s Health Care Conference&lt;/strong&gt;&lt;br/&gt;Date: Wednesday, March 4, 2026&lt;br/&gt;Location: Boston, MA&lt;br/&gt;Time of the fireside chat: 11:10am ET / 5:10pm CET&lt;br/&gt;Presenters: Laurent Levy, Chief Executive Officer of Nanobiotix and Bart van Rhijn, Chief Financial &amp;amp; Business Officer of Nanobiotix&lt;/p&gt; </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/NANOBIOTIX+to+Participate+in+Investor+Conferences+in+March/26060141.html</guid>
   <pubDate>Wed, 25 Feb 2026 16:15:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50100012</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NANO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01217207</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.07579093</category>
   	  </item>
  <item>
   <title>NANO Secures IDR 200 Billion Capital Commitment from LDA Capital to Support Global Transformation</title>
   <link>http://www.streetinsider.com/Press+Releases/NANO+Secures+IDR+200+Billion+Capital+Commitment+from+LDA+Capital+to+Support+Global+Transformation/25781228.html</link>
   <description>
&lt;p&gt;    JAKARTA, Indonesia--(BUSINESS WIRE)--
PT Nanotech Indonesia Global Tbk (“NANO”), a publicly listed technology company on the Indonesia Stock Exchange specializing in R&amp;amp;D-based science and technology services, including nanotechnology and materials engineering, together with its controlling shareholder, PT Nanotech Investama Sedaya, today announced a strategic capital commitment of up to &lt;strong&gt;IDR 200 billion&lt;/strong&gt; from &lt;strong&gt;LDA Capital Group, LLC&lt;/strong&gt;, a global alternative investment group.

&lt;/p&gt;&lt;p&gt;
The facility is structured to support the execution of &lt;strong&gt;IDR 4.95 trillion in secured contracts&lt;/strong&gt; over the next three years, strengthening NANO’s execution-driven growth across projects with national, multinational, and publicly listed companies.

&lt;/p&gt;&lt;p&gt;
To further strengthen its</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/NANO+Secures+IDR+200+Billion+Capital+Commitment+from+LDA+Capital+to+Support+Global+Transformation/25781228.html</guid>
   <pubDate>Mon, 29 Dec 2025 06:29:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NANO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53698096</category>
   	  </item>
  <item>
   <title>NANO Secures IDR 200 Billion Capital Commitment from LDA Capital to Support Global Transformation</title>
   <link>http://www.streetinsider.com/Press+Releases/NANO+Secures+IDR+200+Billion+Capital+Commitment+from+LDA+Capital+to+Support+Global+Transformation/25781228.html</link>
   <description>
&lt;p&gt;    JAKARTA, Indonesia--(BUSINESS WIRE)--
PT Nanotech Indonesia Global Tbk (“NANO”), a publicly listed technology company on the Indonesia Stock Exchange specializing in R&amp;amp;D-based science and technology services, including nanotechnology and materials engineering, together with its controlling shareholder, PT Nanotech Investama Sedaya, today announced a strategic capital commitment of up to &lt;strong&gt;IDR 200 billion&lt;/strong&gt; from &lt;strong&gt;LDA Capital Group, LLC&lt;/strong&gt;, a global alternative investment group.

&lt;/p&gt;&lt;p&gt;
The facility is structured to support the execution of &lt;strong&gt;IDR 4.95 trillion in secured contracts&lt;/strong&gt; over the next three years, strengthening NANO’s execution-driven growth across projects with national, multinational, and publicly listed companies.

&lt;/p&gt;&lt;p&gt;
To further strengthen its</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/NANO+Secures+IDR+200+Billion+Capital+Commitment+from+LDA+Capital+to+Support+Global+Transformation/25781228.html</guid>
   <pubDate>Mon, 29 Dec 2025 06:29:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NANO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53698096</category>
   	  </item>
  <item>
   <title>NANO Secures IDR 200 Billion Capital Commitment from LDA Capital to Support Global Transformation</title>
   <link>http://www.streetinsider.com/Business+Wire/NANO+Secures+IDR+200+Billion+Capital+Commitment+from+LDA+Capital+to+Support+Global+Transformation/25781228.html</link>
   <description>
&lt;p&gt;    JAKARTA, Indonesia--(BUSINESS WIRE)--
PT Nanotech Indonesia Global Tbk (“NANO”), a publicly listed technology company on the Indonesia Stock Exchange specializing in R&amp;amp;D-based science and technology services, including nanotechnology and materials engineering, together with its controlling shareholder, PT Nanotech Investama Sedaya, today announced a strategic capital commitment of up to &lt;strong&gt;IDR 200 billion&lt;/strong&gt; from &lt;strong&gt;LDA Capital Group, LLC&lt;/strong&gt;, a global alternative investment group.

&lt;/p&gt;&lt;p&gt;
The facility is structured to support the execution of &lt;strong&gt;IDR 4.95 trillion in secured contracts&lt;/strong&gt; over the next three years, strengthening NANO’s execution-driven growth across projects with national, multinational, and publicly listed companies.

&lt;/p&gt;&lt;p&gt;
To further strengthen its</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/NANO+Secures+IDR+200+Billion+Capital+Commitment+from+LDA+Capital+to+Support+Global+Transformation/25781228.html</guid>
   <pubDate>Mon, 29 Dec 2025 06:29:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NANO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53698096</category>
   	  </item>
  <item>
   <title>NANO Secures IDR 200 Billion Capital Commitment from LDA Capital to Support Global Transformation</title>
   <link>http://www.streetinsider.com/Business+Wire/NANO+Secures+IDR+200+Billion+Capital+Commitment+from+LDA+Capital+to+Support+Global+Transformation/25781228.html</link>
   <description>
&lt;p&gt;    JAKARTA, Indonesia--(BUSINESS WIRE)--
PT Nanotech Indonesia Global Tbk (“NANO”), a publicly listed technology company on the Indonesia Stock Exchange specializing in R&amp;amp;D-based science and technology services, including nanotechnology and materials engineering, together with its controlling shareholder, PT Nanotech Investama Sedaya, today announced a strategic capital commitment of up to &lt;strong&gt;IDR 200 billion&lt;/strong&gt; from &lt;strong&gt;LDA Capital Group, LLC&lt;/strong&gt;, a global alternative investment group.

&lt;/p&gt;&lt;p&gt;
The facility is structured to support the execution of &lt;strong&gt;IDR 4.95 trillion in secured contracts&lt;/strong&gt; over the next three years, strengthening NANO’s execution-driven growth across projects with national, multinational, and publicly listed companies.

&lt;/p&gt;&lt;p&gt;
To further strengthen its</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/NANO+Secures+IDR+200+Billion+Capital+Commitment+from+LDA+Capital+to+Support+Global+Transformation/25781228.html</guid>
   <pubDate>Mon, 29 Dec 2025 06:29:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NANO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53698096</category>
   	  </item>
  <item>
   <title>Form  6-K        Nanobiotix S.A.           For: Dec 17</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nanobiotix+S.A.+++++++++++For%3A+Dec+17/25753126.html</link>
   <description>si-local-file:///var/storage/secattach/20251217/25753126.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nanobiotix+S.A.+++++++++++For%3A+Dec+17/25753126.html</guid>
   <pubDate>Wed, 17 Dec 2025 16:15:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NANO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01217207</category>
   	  </item>
  <item>
   <title>Form  6-K        Nanobiotix S.A.           For: Dec 17</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nanobiotix+S.A.+++++++++++For%3A+Dec+17/25753126.html</link>
   <description>si-local-file:///var/storage/secattach/20251217/25753126.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nanobiotix+S.A.+++++++++++For%3A+Dec+17/25753126.html</guid>
   <pubDate>Wed, 17 Dec 2025 16:15:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NANO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01217207</category>
   	  </item>
  <item>
   <title>Form  6-K        Nanobiotix S.A.           For: Dec 17</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nanobiotix+S.A.+++++++++++For%3A+Dec+17/25753126.html</link>
   <description>si-local-file:///var/storage/secattach/20251217/25753126.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nanobiotix+S.A.+++++++++++For%3A+Dec+17/25753126.html</guid>
   <pubDate>Wed, 17 Dec 2025 16:15:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NANO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01217207</category>
   	  </item>
  <item>
   <title>Form  6-K        Nanobiotix S.A.           For: Dec 15</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nanobiotix+S.A.+++++++++++For%3A+Dec+15/25737400.html</link>
   <description>si-local-file:///var/storage/secattach/20251215/25737400.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nanobiotix+S.A.+++++++++++For%3A+Dec+15/25737400.html</guid>
   <pubDate>Mon, 15 Dec 2025 06:30:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NANO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01217207</category>
   	  </item>
  <item>
   <title>Form  6-K        Nanobiotix S.A.           For: Dec 15</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nanobiotix+S.A.+++++++++++For%3A+Dec+15/25737400.html</link>
   <description>si-local-file:///var/storage/secattach/20251215/25737400.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nanobiotix+S.A.+++++++++++For%3A+Dec+15/25737400.html</guid>
   <pubDate>Mon, 15 Dec 2025 06:30:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NANO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01217207</category>
   	  </item>
  <item>
   <title>Form  6-K        Nanobiotix S.A.           For: Dec 15</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nanobiotix+S.A.+++++++++++For%3A+Dec+15/25737400.html</link>
   <description>si-local-file:///var/storage/secattach/20251215/25737400.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nanobiotix+S.A.+++++++++++For%3A+Dec+15/25737400.html</guid>
   <pubDate>Mon, 15 Dec 2025 06:30:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NANO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01217207</category>
   	  </item>
  <item>
   <title>Form  6-K        Nanobiotix S.A.           For: Dec 01</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nanobiotix+S.A.+++++++++++For%3A+Dec+01/25683528.html</link>
   <description>si-local-file:///var/storage/secattach/20251201/25683528.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nanobiotix+S.A.+++++++++++For%3A+Dec+01/25683528.html</guid>
   <pubDate>Mon, 01 Dec 2025 16:55:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NANO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01217207</category>
   	  </item>
  <item>
   <title>Form  6-K        Nanobiotix S.A.           For: Dec 01</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nanobiotix+S.A.+++++++++++For%3A+Dec+01/25683528.html</link>
   <description>si-local-file:///var/storage/secattach/20251201/25683528.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Nanobiotix+S.A.+++++++++++For%3A+Dec+01/25683528.html</guid>
   <pubDate>Mon, 01 Dec 2025 16:55:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NANO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NBTX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01217207</category>
   	  </item>
 </channel>
</rss>
